Menu

Chinook Therapeutics, Inc. KDNY

Full chart Compare
Set alert

Price alert · KDNY

All alert types
40.39 +40.39

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $1.56MExpenses → Selling, General & Admin: $36.29MExpenses → Research & Development: $141.21MExpenses → Other Operating Expenses: $13.71MExpenses → Income Tax: $4.34MGross Profit → Expenses: $6.13MRevenue → Gross Profit: $6.13MNet Loss → Expenses: $187.87MOther Income$1.56MGross Profit$6.13MNet Loss$187.87MExpenses$195.55MSelling, General & Admin$36.29MResearch & Development$141.21MOther Operating Expenses$13.71MIncome Tax$4.34MRevenue$6.13M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

KDNY annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
6.13M51.63M827.00K015.09M
6.13M51.63M827.00K015.09M
6.13M51.63M827.00K015.09M
191.21M150.66M57.05M19.97M116.45M
141.21M96.99M36.05M17.01M75.84M
36.29M31.90M19.07M2.96M36.03M
-185.08M-99.04M-56.23M-19.97M-101.36M
4.34M2.09M-2.00M0-783.00K
-187.87M-102.94M-81.62M-46.52M-95.36M
-187.87M-102.94M-81.62M-46.52M-95.36M
-187.87M-102.94M-81.62M-46.52M-95.36M
-187.87M-102.94M-81.62M-46.52M-95.36M
-2.92-2.26-6.20-25.48-6.05
-2.92-2.26-6.20-25.48-6.05
-2.92-2.26-6.20-25.48-6.05
-183.52M-100.84M-83.63M-46.49M-101.42M
-183.52M-100.84M-83.63M-46.49M-101.42M
64.37M45.61M13.17M1.83M15.76M
64.37M45.61M13.17M1.83M15.76M